Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies
Open Access

Kelch-like Protein 11 (KLHL11) Antibodies in Children With Seizures of Undetermined Cause

JOHN TZARTOS, MARIA PECHLIVANIDOU, DESPOINA BOSVELI, ELPINICKIE NINOU, HANDE YUCEER, BEYZANUR YALCIN, CEM ISMAIL KUCUKALI, ERDEM TUZUN, SOCRATES TZARTOS and DILSAD TURKDOGAN
In Vivo January 2024, 38 (1) 351-357; DOI: https://doi.org/10.21873/invivo.13445
JOHN TZARTOS
12nd Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, “Attikon” University Hospital, Athens, Greece;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARIA PECHLIVANIDOU
2Tzartos NeuroDiagnostics, Athens, Greece;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DESPOINA BOSVELI
2Tzartos NeuroDiagnostics, Athens, Greece;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ELPINICKIE NINOU
2Tzartos NeuroDiagnostics, Athens, Greece;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HANDE YUCEER
3Department of Neuroscience, Aziz Sancar Institute for Experimental Medical Research, Istanbul University, Istanbul, Turkey;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BEYZANUR YALCIN
3Department of Neuroscience, Aziz Sancar Institute for Experimental Medical Research, Istanbul University, Istanbul, Turkey;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CEM ISMAIL KUCUKALI
3Department of Neuroscience, Aziz Sancar Institute for Experimental Medical Research, Istanbul University, Istanbul, Turkey;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ERDEM TUZUN
3Department of Neuroscience, Aziz Sancar Institute for Experimental Medical Research, Istanbul University, Istanbul, Turkey;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: drerdem{at}yahoo.com
SOCRATES TZARTOS
2Tzartos NeuroDiagnostics, Athens, Greece;
4Department of Neurobiology, Hellenic Pasteur Institute, Athens, Greece;
5Department of Pharmacy, University of Patras, Patras, Greece;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DILSAD TURKDOGAN
6Division of Child Neurology, Department of Pediatrics, Faculty of Medicine, Marmara University, Istanbul, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Cell-based assay results. Transfected HEK293 cells expressing Kelch-like protein 11 (KLHL11) antigen were incubated with sera from (A) patients with paraneoplastic neurological disorders, (B) patients diagnosed with pediatric epilepsy of undetermined cause, (D) patients with myelin oligodendrocyte (MOG) antibody-associated disease and (E) healthy controls. Transfected cells were also incubated with commercial rabbit anti-KLHL11 IgG (red, C). Some patients with (A) paraneoplastic disorders and (B) with pediatric epilepsy were found positive for KLHL11 antibody at 1/1,000 dilution, whereas (D) the patient with MOG-antibody positive sera and (E) a healthy control gave no staining at 1/100 dilution. (F) HEK293 cells expressing glial fibrillary acidic protein (GFAP) did not immunoreact with patient sera or the commercial antibody. Scale bar: 20 μm. Note that the dot-like reactivity present in the GFAP-transfected HEK293 cells is considered as a background noise and is due to the non-specific proteins which are present in the human serum.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Co-localization studies with sera of patients and commercial Kelch-like protein 11 (KLHL11) antibody (Ab). (A, D) Reactivity (red) of sera of representative KLHL11 Ab positive patients with paraneoplastic neurological disorder (PNS) and pediatric epilepsy with HEK293 cells expressing KLHL11. (B, E) Reactivity (green) of a commercial KLHL11 Ab. (C, F) the commercial Ab shows significant co-localization with patients’ antibodies (yellow). Original magnification 40×.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Immunolabeling (brown color) of frozen rat brain sections with sera of Kelch-like protein 11 (KLHL11) antibody (Ab) positive and negative pediatric epilepsy (PE) patients and a healthy control. Sera of PE patients with KLHL11 Ab show cytoplasmic staining in neurons of deep cerebellar nuclei and brainstem (leftmost two columns), whereas no appreciable immunoreactivity is observed with sera of antibody negative PE patients and healthy control (rightmost two columns; original magnification 40×).

Tables

  • Figures
  • Table I.
PreviousNext
Back to top

In this issue

In Vivo: 38 (1)
In Vivo
Vol. 38, Issue 1
January-February 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Kelch-like Protein 11 (KLHL11) Antibodies in Children With Seizures of Undetermined Cause
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
8 + 11 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Kelch-like Protein 11 (KLHL11) Antibodies in Children With Seizures of Undetermined Cause
JOHN TZARTOS, MARIA PECHLIVANIDOU, DESPOINA BOSVELI, ELPINICKIE NINOU, HANDE YUCEER, BEYZANUR YALCIN, CEM ISMAIL KUCUKALI, ERDEM TUZUN, SOCRATES TZARTOS, DILSAD TURKDOGAN
In Vivo Jan 2024, 38 (1) 351-357; DOI: 10.21873/invivo.13445

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Kelch-like Protein 11 (KLHL11) Antibodies in Children With Seizures of Undetermined Cause
JOHN TZARTOS, MARIA PECHLIVANIDOU, DESPOINA BOSVELI, ELPINICKIE NINOU, HANDE YUCEER, BEYZANUR YALCIN, CEM ISMAIL KUCUKALI, ERDEM TUZUN, SOCRATES TZARTOS, DILSAD TURKDOGAN
In Vivo Jan 2024, 38 (1) 351-357; DOI: 10.21873/invivo.13445
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Clinical and Biochemical Predictors of 30-Day Mortality After Decompressive Craniectomy: A Retrospective Cohort Study
  • Prognostic and Predictive Factors for Patients With Gastric Cancer who Are Positive for Peritoneal Lavage Cytology and Negative for Other Distant Metastasis
  • Adjunctive Molecular Hydrogen Therapy Modulates T Cell Markers and Reduces Anti-Ro Antibody in Refractory Oral Ulcers of Behçet’s Disease and Sjögren’s Syndrome: A Case Report
Show more Clinical Studies

Keywords

  • Kelch-like protein 11
  • antibody
  • epilepsy
  • seizures
  • autoimmunity
In Vivo

© 2026 In Vivo

Powered by HighWire